Resources for Food and Drug Administration (FDA)

FDA flub tied to heparin scare

www.pittsburghlive.co

A name mix-up by American drug inspectors allowed a Chinese factory to supply the United States with a widely used blood thinner linked to life-threatening allergic reactions in Pennsylvania and at least 11 states, federal Food and Drug Administration officials said Monday.

U.S. inspectors plan to investigate Changzhou Scientific Protein Laboratories, which supplied ingredients for injectable heparin manufactured by Illinois-based Baxter Healthcare Corp. The company stopped manufacturing the drug last week after it was blamed for hundreds of severe allergic reactions, mostly in dialysis patients.

View the Resource

Share or bookmarklet this web page at: